Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
ACP-204 Alzheimer's Disease (Phase 2/3) Acadia Pharmaceuticals Other Neurotransmitters Small Molecule
AXS-05 Dextromethorphan/bupropion,
Auvelity
Alzheimer's Disease (Phase 2/3) Axsome Therapeutics, Inc. Other Neurotransmitters Combination, Small Molecule Major depressive disorder